text_1: Pioglitazone use is significantly associated with an increased risk of pancreatic cancer.
text_2: CONCLUSIONS AND RELEVANCE Pioglitazone use was not associated with a statistically significant increased risk of bladder cancer, although an increased risk, as previously observed, could not be excluded.